Cambridge Investment Research Advisors
IBDN

Cambridge Investment Research Advisors’s iShares iBonds Dec 2022 Term Corporate ETF IBDN Stock Holding History

Cambridge Investment Research Advisors’s Portfolio IBDN Stock Details IBDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-106,000
Closed -$2.65M – 3280
2022
Q3 		$2.65M Sell
106,000
-1,910
-2% -$47.8K 0.01% 893
2022
Q2 		$2.7M Buy
107,910
+40,339
+60% +$1.01M 0.01% 897
2022
Q1 		$1.69M Buy
67,571
+43,517
+181% +$1.09M 0.01% 1241
2021
Q4 		$605K Sell
24,054
-1,094
-4% -$27.6K ﹤0.01% 1954
2021
Q3 		$637K Sell
25,148
-16,110
-39% -$408K ﹤0.01% 1861
2021
Q2 		$1.05M Sell
41,258
-15,700
-28% -$399K 0.01% 1501
2021
Q1 		$1.45M Sell
56,958
-66,971
-54% -$1.71M 0.01% 1195
2020
Q4 		$3.17M Buy
123,929
+13,276
+12% +$340K 0.02% 687
2020
Q3 		$2.84M Buy
110,653
+3,137
+3% +$80.5K 0.02% 646
2020
Q2 		$2.76M Buy
107,516
+14,202
+15% +$361K 0.02% 640
2020
Q1 		$2.31M Sell
93,314
-6,712
-7% -$168K 0.02% 612
2019
Q4 		$2.53M Buy
100,026
+79,014
+376% +$2M 0.02% 693
2019
Q3 		$532K Buy
21,012
+8,044
+62% +$203K ﹤0.01% 1460
2019
Q2 		$327K Buy
12,968
+969
+8% +$24.2K ﹤0.01% 1693
2019
Q1 		$299K Sell
11,999
-623
-5% -$15.3K ﹤0.01% 1808
2018
Q4 		$305K Buy
+12,622
New +$305K ﹤0.01% 1652
2018
Q1 		– Sell
-9,146
Closed -$228K – 2294
2017
Q4 		$228K Sell
9,146
-449
-5% -$11.3K ﹤0.01% 1836
2017
Q3 		$242K Sell
9,595
-700
-7% -$17.7K ﹤0.01% 1699
2017
Q2 		$259K Buy
+10,295
New +$259K ﹤0.01% 1600

Other funds holding IBDN

OIA
Optimum Investment Advisors Chicago, Illinois $252M AUM 26.44% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Cambridge Investment Research Advisors's IBDN Position: Q4 2022 in Review

Cambridge Investment Research Advisors sold out of iShares iBonds Dec 2022 Term Corporate ETF (IBDN) in Q4 2022, closing a stake of 106,000 shares — an estimated $2.65M sold.

Cambridge Investment Research Advisors first reported a position in IBDN in Q2 2017 and held it in 19 quarters. The position peaked at $3.17M in Q4 2020. 2 funds tracked by Wall St. Rank hold IBDN as of Q4 2022.

  • Cambridge Investment Research Advisors reported no remaining iShares iBonds Dec 2022 Term Corporate ETF position as of Q4 2022 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 106,000 iShares iBonds Dec 2022 Term Corporate ETF shares in Q4 2022, an estimated $2.65M.
  • Cambridge Investment Research Advisors first reported a position in iShares iBonds Dec 2022 Term Corporate ETF in Q2 2017 and held it in 19 quarters.
  • Cambridge Investment Research Advisors's iShares iBonds Dec 2022 Term Corporate ETF position peaked at $3.17M in Q4 2020.
  • 2 funds tracked by Wall St. Rank held iShares iBonds Dec 2022 Term Corporate ETF as of Q4 2022.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2022, filed 8 Feb 2023.